These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 19228728)
1. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG. Ghosh AK; Kay NE; Secreto CR; Shanafelt TD Clin Cancer Res; 2009 Feb; 15(4):1250-8. PubMed ID: 19228728 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways. Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes prosurvival stimuli to induce apoptosis in chronic lymphocytic leukemia cells. Cosimo E; McCaig AM; Carter-Brzezinski LJ; Wheadon H; Leach MT; Le Ster K; Berthou C; Durieu E; Oumata N; Galons H; Meijer L; Michie AM Clin Cancer Res; 2013 May; 19(9):2393-405. PubMed ID: 23532892 [TBL] [Abstract][Full Text] [Related]
4. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Lee YK; Bone ND; Strege AK; Shanafelt TD; Jelinek DF; Kay NE Blood; 2004 Aug; 104(3):788-94. PubMed ID: 14996703 [TBL] [Abstract][Full Text] [Related]
5. Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia. Angelo LS; Kurzrock R Clin Cancer Res; 2009 Feb; 15(4):1123-5. PubMed ID: 19228716 [TBL] [Abstract][Full Text] [Related]
6. STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia. Liu FT; Jia L; Wang P; Wang H; Farren TW; Agrawal SG Oncotarget; 2016 May; 7(22):32031-45. PubMed ID: 27074565 [TBL] [Abstract][Full Text] [Related]
7. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Longo PG; Laurenti L; Gobessi S; Sica S; Leone G; Efremov DG Blood; 2008 Jan; 111(2):846-55. PubMed ID: 17928528 [TBL] [Abstract][Full Text] [Related]
8. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals. McCaig AM; Cosimo E; Leach MT; Michie AM Br J Haematol; 2011 Apr; 153(2):199-211. PubMed ID: 21352196 [TBL] [Abstract][Full Text] [Related]
9. Preclinical assessment of curcumin as a potential therapy for B-CLL. Everett PC; Meyers JA; Makkinje A; Rabbi M; Lerner A Am J Hematol; 2007 Jan; 82(1):23-30. PubMed ID: 16947318 [TBL] [Abstract][Full Text] [Related]
14. The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells. Godbersen JC; Humphries LA; Danilova OV; Kebbekus PE; Brown JR; Eastman A; Danilov AV Clin Cancer Res; 2014 Mar; 20(6):1576-89. PubMed ID: 24634471 [TBL] [Abstract][Full Text] [Related]
15. AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia. Yi X; Sarkar A; Kismali G; Aslan B; Ayres M; Iles LR; Keating MJ; Wierda WG; Long JP; Bertilaccio MTS; Gandhi V Clin Cancer Res; 2020 Jul; 26(14):3856-3867. PubMed ID: 31937611 [TBL] [Abstract][Full Text] [Related]
16. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. Lu K; Fang XS; Feng LL; Jiang YJ; Zhou XX; Liu X; Li PP; Chen N; Ding M; Wang N; Zhang J; Wang X Cancer Lett; 2015 Apr; 359(2):250-8. PubMed ID: 25636517 [TBL] [Abstract][Full Text] [Related]
17. Green tea polyphenol "epigallocatechin-3-gallate", differentially induces apoptosis in CLL B-and T-Cells but not in healthy B-and T-Cells in a dose dependant manner. Cornwall S; Cull G; Joske D; Ghassemifar R Leuk Res; 2016 Dec; 51():56-61. PubMed ID: 27855324 [TBL] [Abstract][Full Text] [Related]
18. Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model. Rebolleda N; Losada-Fernandez I; Perez-Chacon G; Castejon R; Rosado S; Morado M; Vallejo-Cremades MT; Martinez A; Vargas-Nuñez JA; Perez-Aciego P PLoS One; 2016; 11(4):e0154159. PubMed ID: 27101369 [TBL] [Abstract][Full Text] [Related]
19. Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms. Zhang W; Pelicano H; Yin R; Zeng J; Wen T; Ding L; Huang R Mol Med Rep; 2015 Nov; 12(5):7374-88. PubMed ID: 26458979 [TBL] [Abstract][Full Text] [Related]
20. AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance. Balakrishnan K; Burger JA; Wierda WG; Gandhi V Blood; 2009 Jan; 113(1):149-53. PubMed ID: 18836097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]